pemetrexed baxter
baxter holding b.v. - pemetrexed disodium heptahydrate - carcinoma, non-small-cell lung; mesothelioma - daganatellenes szerek - malignant pleural mesotheliomapemetrexed baxter in combination with cisplatin is indicated for the treatment of chemotherapy naïve patients with unresectable malignant pleural mesothelioma. non-small cell lung cancerpemetrexed baxter in combination with cisplatin is indicated for the first line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5. pemetrexed baxter is indicated as monotherapy for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology in patients whose disease has not progressed immediately following platinum-based chemotherapy (see section 5. pemetrexed baxter is indicated as monotherapy for the second line treatment of patients with locally advanced or metastatic non-small cell lung cancer other than predominantly squamous cell histology (see section 5.
onkotrone 25 mg/12,5 ml injekció
baxter oncology gmbh - mitoxantrone -
onkotrone 30 mg/15 ml injekció
baxter oncology gmbh - mitoxantrone -
miltex 6% oldat
baxter oncology gmbh - miltefosine -
endoxan 200 mg injekció
baxter oncology gmbh - ciklofoszfamid -
onkotrone 20 mg/10 ml injekció
baxter oncology gmbh - mitoxantrone -
glükóz 5% "baxter" infúzió 100 ml
baxter (hungary) kft. - glükóz, vízmentes -
glükóz 5% "baxter" infúzió 250 ml
baxter (hungary) kft. - glükóz, vízmentes -
glükóz 5% "baxter" infúzió 1000 ml
baxter (hungary) kft. - glükóz, vízmentes -
glükóz 5% "baxter" infúzió 500 ml
baxter (hungary) kft. - glükóz, vízmentes -